Reading the literature, you would think that as nephrology professionals, we cannot make up our minds. "Start a patient early for the best outcomes" or "start a patient as late as possible to improve their mortality." What do you believe? Listen to a discussion of the different opinions regarding this controversial issue.
Contact hours available until 9/22/2015.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.
Conflict of Interest Disclosure:
Speaker(s) have no disclosures to declare.
Conference Committee Disclosures:
Dawn Koonkongsatian – Employee, Fresenius Medical Care
Kristin Larson – Employee, NxStage Medical
Denise Murcek – Employee, Fresenius Medical Care
Beth St. John - Employee, Fresenius Medical Care
Lucy Todd – Employee, Baxter Healthcare
Kyra Trappett – Employee, DaVita
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
Accreditation Statement:
American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Objectives:
- Discuss the issues surrounding when to initiate kidney replacement therapies.
- Debate the controversy between early and late initiation of acute dialysis therapies.
- Debate the controversy between early and late initiation of chronic dialysis therapies.
